Innovative Eyewear Inc (LUCY)
0.23
+0.01
(+6.48%)
USD |
NASDAQ |
May 03, 16:00
0.2307
0.00 (0.00%)
After-Hours: 20:00
Innovative Eyewear Research and Development Expense (Quarterly): 0.1208M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1208M |
| September 30, 2023 | 0.1927M |
| June 30, 2023 | 0.1975M |
| March 31, 2023 | 0.1512M |
| December 31, 2022 | 0.1316M |
| September 30, 2022 | 0.3047M |
| June 30, 2022 | 0.0526M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0358M |
| December 31, 2021 | 0.0501M |
| September 30, 2021 | 0.0092M |
| June 30, 2021 | 0.0191M |
| March 31, 2021 | 0.0078M |
| December 31, 2020 | 0.0061M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.0061M
Minimum
Dec 2020
0.3047M
Maximum
Sep 2022
0.0984M
Average
0.0526M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Anika Therapeutics Inc | 7.585M |
| The Cooper Companies Inc | 39.50M |
| Staar Surgical Co | 10.87M |
| OrthoPediatrics Corp | 2.747M |
| NexGel Inc | 0.013M |